Cite
HARVARD Citation
Shen, S. et al. (2018). A multi‐omic study reveals BTG2 as a reliable prognostic marker for early‐stage non‐small cell lung cancer. Molecular oncology. 12 (6), pp. 913-924. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shen, S. et al. (2018). A multi‐omic study reveals BTG2 as a reliable prognostic marker for early‐stage non‐small cell lung cancer. Molecular oncology. 12 (6), pp. 913-924. [Online].